New shot aims to slow devastating brain disease
NCT ID NCT07217665
Summary
This study is testing an investigational drug called AADvac1 to see if it is safe and can slow the progression of Progressive Supranuclear Palsy (PSP), a rare and serious brain disorder. About 146 people with early-stage PSP will be randomly assigned to receive either the active drug or a placebo. The main goal is to see if the drug can reduce the worsening of symptoms and disability over time.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSP - PROGRESSIVE SUPRANUCLEAR PALSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.